High-Density Lipoproteins and the Kidney
Dyslipidemia is a typical trait of patients with chronic kidney disease (CKD) and it is typically characterized by reduced high-density lipoprotein (HDL)-cholesterol(c) levels. The low HDL-c concentration is the only lipid alteration associated with the progression of renal disease in mild-to-modera...
Main Authors: | Arianna Strazzella, Alice Ossoli, Laura Calabresi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/4/764 |
Similar Items
-
Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease
by: Andrea Baragetti, et al.
Published: (2020-07-01) -
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
by: Alice Ossoli, et al.
Published: (2016-06-01) -
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort
by: Chiara Pavanello, et al.
Published: (2020-12-01) -
LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice[S]
by: Sophie Stukas, et al.
Published: (2014-08-01) -
Exchange of phospholipids between low and high density lipoproteins of squirrel monkeys
by: D. Roger Illingworth, et al.
Published: (1972-03-01)